Inventor
DECRULLE ANTOINE
FR24 patents
Patents
24 patentsUS11541106B2Jan 3, 2023
Method for killing bacteria with an engineered postbiotic
ELIGO BIOSCIENCE7 citations85
US10808254B2Oct 20, 2020
Optimized vector for delivery in microbial populations
ELIGO BIOSCIENCE4 citations83
US11224621B2Jan 18, 2022
Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders
ELIGO BIOSCIENCE4 citations81
US11633348B2Apr 25, 2023
Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysins
ELIGO BIOSCIENCE4 citations74
US11839645B2Dec 12, 2023
Therapeutic use of engineered postbiotics comprising bacteriocins and/or endolysins
ELIGO BIOSCIENCE1 citations72
US11078490B2Aug 3, 2021
Optimized vector for delivery in microbial populations
ELIGO BIOSCIENCE3 citations72
US11690880B2Jul 4, 2023
Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders
ELIGO BIOSCIENCE3 citations70
US11534467B2Dec 27, 2022
Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders
ELIGO BIOSCIENCE1 citations70
US11473093B2Oct 18, 2022
Cutibacterium acnes recombinant phages, method of production and uses thereof
ELIGO BIOSCIENCE1 citations70
US11739304B2Aug 29, 2023
Production of lytic phages
ELIGO BIOSCIENCE2 citations69
US11124776B2Sep 21, 2021
Pharmaceutical compositions comprising bacterial delivery vehicles and uses thereof
ELIGO BIOSCIENCE2 citations69
US11376286B2Jul 5, 2022
Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders
ELIGO BIOSCIENCE1 citations67
US12214070B2Feb 4, 2025
Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysins
ELIGO BIOSCIENCE0 citations62
US11946056B2Apr 2, 2024
Optimized vector for delivery in microbial populations
ELIGO BIOSCIENCE0 citations62
US11905516B2Feb 20, 2024
Optimized vector for delivery in microbial populations
ELIGO BIOSCIENCE0 citations62
US12460216B2Nov 4, 2025
Phage-derived particles for in situ delivery of DNA payload into C. acnes population
ELIGO BIOSCIENCE0 citations59
US12454696B2Oct 28, 2025
Cutibacterium acnes recombinant phages encoding a human protein
ELIGO BIOSCIENCE0 citations59
US11970701B2Apr 30, 2024
Phage-derived particles for in situ delivery of DNA payload into C. acnes population
ELIGO BIOSCIENCE0 citations59
US11952594B2Apr 9, 2024
Pharmaceutical compositions comprising bacterial delivery vehicles and uses thereof
ELIGO BIOSCIENCE0 citations59
US11939598B2Mar 26, 2024
Production bacterial cells and use thereof in production methods
ELIGO BIOSCIENCE0 citations59
US11840695B2Dec 12, 2023
Recombinant C. acnes phages comprising transgenes
ELIGO BIOSCIENCE0 citations59
US11820989B2Nov 21, 2023
Phage-derived particles for in situ delivery of DNA payload into C. acnes population
ELIGO BIOSCIENCE0 citations59
US11697802B2Jul 11, 2023
Production bacterial cells and use thereof in production methods
ELIGO BIOSCIENCE0 citations59
US11952595B2Apr 9, 2024
Production of lytic phages
ELIGO BIOSCIENCE0 citations56